Stoma-site approach single-port laparoscopic versus conventional multi-port laparoscopic Miles procedure for low rectal cancer: A prospective, randomized controlled trial

Abstract

The aim of this study was to compare perioperative outcomes of patients with low rectal cancer after stoma-site approach single-port laparoscopic Miles procedure or conventional multi-port laparoscopic Miles procedure, as well as to evaluate the safety and efficacy of stoma-site approach single-port laparoscopic surgery in low rectal cancer. Between September 2020 and September 2021, 51 low rectal cancer patients scheduled for Miles procedure at the Department of Gastrointestinal Surgery of Affiliated Hospital of North Sichuan Medical College were randomly assigned to the single-port laparoscopic surgery group (SPLS) and the multi-port laparoscopic surgery (MPLS) group. The perioperative outcomes were compared between the two groups. In this study, 25 patients underwent SPLS and 26 underwent MPLS. All patients completed the study, and there were no perioperative deaths in either group. Observation indicators such as intraoperative bleeding (39mL vs. 41mL), number of lymph nodes (20.12±3.29 vs. 21.84±3.74), average hospital stay (7.15±1.52 vs. 7.64±1.66), and time to flatulence (2.5d vs. 2.5d) showed no significant differences between the SPLS and MPLS groups (p>0.05). However, the operation duration (180min vs. 118 min) and perioperative complications showed statistically significant differences between the two groups (p<0.05). In addition, patients in the SPLS group had significantly higher satisfaction scores than those in the MPLS group (p<0.05). For patients with low rectal cancer requiring Miles surgery, stoma-site approach single-port laparoscopic surgery has comparable safety and efficacy to multi-port laparoscopic surgery.